Cargando…
Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion
Acute lymphoblastic leukemia (ALL) with recurrent genetic lesions, affecting a series of kinase genes, is associated with unfavorable prognosis, however, it could benefit from treatment with tyrosine kinase inhibitors (TKI). NUP214::ABL1 fusion is detected in 6% of T-cell acute lymphoblastic leukemi...
Autores principales: | Stukaite-Ruibiene, Egle, Norvilas, Rimvydas, Dirse, Vaidas, Stankeviciene, Sigita, Vaitkeviciene, Goda Elizabeta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510372/ https://www.ncbi.nlm.nih.gov/pubmed/36172171 http://dx.doi.org/10.3389/pore.2022.1610570 |
Ejemplares similares
-
Low incidence of ABL-class and JAK-STAT signaling pathway alterations in uniformly treated pediatric and adult B-cell acute lymphoblastic leukemia patients using MRD risk-directed approach – a population-based study
por: Norvilas, Rimvydas, et al.
Publicado: (2021) -
Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy
por: Nardi, Valentina, et al.
Publicado: (2022) -
Detection of a cryptic NUP214/ABL1 gene fusion by mate-pair sequencing (MPseq) in a newly diagnosed case of pediatric T-lymphoblastic leukemia
por: Peterson, Jess F., et al.
Publicado: (2019) -
Detection of NUP214-ABL1 translocation using BCR-ABL1 dual color FISH probes in T-cell acute lymphoblastic leukemia–an illustrative report and review of literature
por: Virk, Harpreet, et al.
Publicado: (2022) -
Development of a questionnaire to evaluate female fertility care in pediatric oncology, a TREL initiative
por: van der Perk, M. E. Madeleine, et al.
Publicado: (2022)